LCD L36155: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) — Noridian
Policy LCD-L36155 · Hematology
New LCD for genetic testing could impact billing processes.
Code intelligence
Z83.79 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code Z83.79.
Elevated code riskView ICD-10 detail
Signal breakdown
5 shown · 5 total in platform
Risk: Elevated
0
Critical
0%
4
High
80%
1
Routine
20%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
Proposed LCD DL40274: MolDX: Genetic Testing for Hereditary Thrombophilia — WPS
Policy LCD-DL40274 · Hematology
New LCD requires billing team review.
Proposed LCD DL40238: MolDX: Genetic Testing for Hereditary Thrombophilia — Palmetto GBA
Policy LCD-DL40238 · Hematology
Impact on billing for hereditary thrombophilia testing.
Proposed LCD DL40259: MolDX: Genetic Testing for Hereditary Thrombophilia — CGS
Policy LCD-DL40259 · Hematology
Impact on genetic testing billing for thrombophilia.
LCD L38351: MolDX: Repeat Germline Testing — Noridian
Policy LCD-L38351 · Oncology
New guidelines for repeat germline testing could impact reimbursements.
Audit documentation
Building an audit file that includes Z83.79?
The Tripwire Audit Pack exports 12 months of Hematology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Hematology audit pack — $349One-time purchase · not a subscription